Brief: Omnicell Q2 Revenue USD 277 Million Vs. IBES Estimate USD 255.2 Million
01/08/2024 11:30
Aug 01 (Reuters) - Omnicell Q2 adjusted EBITDA USD 40 million vs. IBES estimate USD 16.8 million. * Q2 adjusted net income USD 24 million vs. IBES estimate USD 6.69 million * Q2 net income USD 4 million * outlook Q3 adjusted EBITDA USD 28-34 million * outlook FY adjusted EBITDA USD 105-125 million
Recent news on Omnicell
See all newsBrief: Omnicell Welcomes Hospital Pharmacy Leader Rick Couldry As Senior Vice President
Omnicell Q1 adjusted EPS beats helped by connected devices demand, raises FY outlook
U.S. RESEARCH ROUNDUP-Amazon, Estée Lauder, Ralph Lauren
Omnicell Q4 EPS misses estimates
Omnicell Q3 adjusted EPS beats estimates, driven by connected devices and services